Khatchapuridze Khatuna, Kekelidze Nino, Tsitsishvili Zaza, Mchedlishvili Maia, Kordzaia Dimitri
Ivane Javakhishvili Tbilisi State University Faculty of Medicine, Tbilisi, Georgia.
New Vision University Hospital, Tbilisi, Georgia.
Gynecol Endocrinol. 2020 Aug;36(8):749-752. doi: 10.1080/09513590.2020.1725966. Epub 2020 Feb 11.
Struma Ovarii is one of the types of mature teratoma, with predominant thyroid tissue (>50%). It occurs in 1% of all cases of ovarian tumors and in 2.7% of dermoid tumors. There are no specific clinical, radiological or serum markers for this rare pathology. Rarely it may be accompanied by ascites and the increased level of CA-125. In general Stuma Ovarii is clinically defined as an ovarian malignancy. It is diagnosed only by histopathological examination of the surgical material. Diagnosis of Struma Ovarii dictates the need for advanced research of the thyroid. Struma Ovarii is mostly benign. Its malignant transformation occurs in only 5% of all cases, That leads to further management planning analogous to the treatment of thyroid cancer. The case of malignant Struma Ovarii of the 50-year-old woman, which led to total thyroidectomy and radioactive iodine therapy - is described.
卵巢甲状腺肿是成熟畸胎瘤的一种类型,以甲状腺组织为主(>50%)。它在所有卵巢肿瘤病例中占1%,在皮样囊肿中占2.7%。对于这种罕见的病理情况,没有特定的临床、放射学或血清标志物。极少数情况下,它可能伴有腹水和CA - 125水平升高。一般来说,卵巢甲状腺肿在临床上被定义为卵巢恶性肿瘤。它仅通过手术材料的组织病理学检查来诊断。卵巢甲状腺肿的诊断需要对甲状腺进行进一步的深入研究。卵巢甲状腺肿大多为良性。其恶变仅发生在所有病例的5%中,这导致了类似于甲状腺癌治疗的进一步管理规划。本文描述了一名50岁女性的恶性卵巢甲状腺肿病例,该病例导致了全甲状腺切除术和放射性碘治疗。